April 2012

ICO receives the highest international distinction for his fight against smoking

Leave a Comment / Cancer, Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Tobacco control research  / By

The Catalan Institute of Oncology (ICO) L’Hospitalet has been recognized with the ‘gold standard’ of the Global Network for Tobacco Free Health Care Services (ENSH). This is the highest international distinction given to those health centers that have demonstrated significant progress in tobacco control policies and represent an example for other organizations in the fight […]

ICO receives the highest international distinction for his fight against smoking Read More »

The University Hospital of Bellvitge receives one of the Profesor Barea Awards 2012 on health management

Leave a Comment / Sin categorizar / By

On 19 April, the Signo Foundation presented the Profesor Barea Awards 2012, an initiative to highlight and recognize the work of public and private institutions to improve health management and development of new initiatives that seek to optimize the healthcare services. In the category “Healthcare facilities and service companies: Global Management” has been awarded the

The University Hospital of Bellvitge receives one of the Profesor Barea Awards 2012 on health management Read More »

Núria Malats: ”the challenge of epidemiology is to analyze all information relating to a disease”

Leave a Comment / Sin categorizar / By

The integration of different levels of information associated with a disease, such as issues related to environmental exposure, epigenetics, genetics, genomics, metabolomics, transcriptomics and proteomics, requires the development of innovative designs and new methodological tools. The head of the research group on Molecular Epidemiology and Genetics at the Spanish National Cancer Research Centre (CNIO), Núria

Núria Malats: ”the challenge of epidemiology is to analyze all information relating to a disease” Read More »

IDIBELL researches to cure cystic fibrosis

Leave a Comment / Genes, Disease and Therapy Program, Human Molecular Genetics, Immune-inflammatory Processes and Gene Therapeutics, Translational Medicine Area / By

On Wednesday April 25 we commemorate the national day of cystic fibrosis, one of the most common serious genetic diseases, affecting one in five thousand births. The Human Molecular Genetics research group at IDIBELL searches new treatments for cystic fibrosis, both from a functional approach and from the development of gene therapies. The research carried

IDIBELL researches to cure cystic fibrosis Read More »

Jesús San Miguel: ”The goal is to demonstrate that early treatment against pre-myeloma improves survival”

Leave a Comment / Sin categorizar / By

One of the foremost experts in the field of multiple myeloma, Jesus San Miguel, explained in IDIBELL seminar series on 13 April, the approach to this disease that makes his research group at the University Hospital of Salamanca. The researcher explained that one objective is to understand the pathogenesis of the disease: “We want to

Jesús San Miguel: ”The goal is to demonstrate that early treatment against pre-myeloma improves survival” Read More »

Manel Esteller, chosen Elect Academic of the Royal Academy of Medicine of Catalonia

Leave a Comment / Cancer Epigenetics / By

The researcher Manel Esteller, director of the Cancer and Epigenetics Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), Professor of Genetics at the University of Barcelona and ICREA Research Professor has chosen Academic Elect of the Royal Academy of Medicine of Catalonia (RAMC). Esteller will occupy the space left by Moises Broggi, Creu de

Manel Esteller, chosen Elect Academic of the Royal Academy of Medicine of Catalonia Read More »

Oriol Casanovas reviews limitations of antiangiogenic therapies at Nature

Leave a Comment / Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Tumour Angiogenesis / By

IDIBELL researcher Oriol Casanovas has published in the latest issue of Nature an article titled “Limitations of therapies exposed” where he highlights the need to know the limitations of antiangiogenic therapies to open doors to new combinations and therapeutic approaches that involve greater benefits for patients. Specifically, Casanovas comments two recent publications which expose the

Oriol Casanovas reviews limitations of antiangiogenic therapies at Nature Read More »

IDIBELL, epigenetics and scientific career at Nature

Leave a Comment / Cancer Epigenetics / By

The scientific journal Nature includes in its issue of March 29th an article that analyzes investment opportunities and development of scientific careers in the field of epigenetics. In the article, the director of the Cancer Epigenetics and Biology Program of the IDIBELL, ICREA researcher and professor at the University of Barcelona, Manel Esteller, highlights the

IDIBELL, epigenetics and scientific career at Nature Read More »

Identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients

Leave a Comment / Cancer, Colorectal Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

Researchers from the IDIBELL have shown that breast cancer cells that metastasize to the lung express a higher level of the protein peroxiredoxin 2 (PRDX2). The study suggests that the modulation of the levels of this protein could be a new therapeutic strategy to prevent lung metastases. The study results have been advanced in the

Identified a protein useful in predicting the risk of pulmonary metastases in breast cancer patients Read More »

La Vanguardia publishes an article on innovation, by the IDIBELL general manager

Leave a Comment / Uncategorised / By

The newspaper La Vanguardia publishes today an article written by the IDIBELL general manager, Emilià Pola, warning about the low priority given to innovation in our country. Pola highlights the paradox that “while Spain is the first country in the world to perform the most complex surgeries [referring to transplantations] and our hospitals are an

La Vanguardia publishes an article on innovation, by the IDIBELL general manager Read More »

Scroll to Top